Shares in Roadman Investments Corp. (TSX-V: LITT, OTC: RMANF, Forum) saw a solid bump in early Friday trading, after the Company announced that it had acquired CLOV Biopharma Corp., a company developing cedar leaf oil vapour to help stop the spread of the deadly COVID-19 Coronavirus and other similar potentially pathogenic respiratory viruses.
For more on this news, click here.
Roadman, a Canadian venture capital & advisory firm, signed the letter of intent to acquire all of CLOV’s shares earlier this week and it intends to use its exclusive license to manufacture or source a diffuser that is functional with cedar oil that may be effective in killing viruses to prevent them from spreading.
FULL DISCLOSURE: Roadman Investments Corp. is a client of Stockhouse Publishing.